Literature DB >> 29759053

Histopathologic and Immunohistochemistry Findings in Feline Renal Cell Carcinoma.

Isao Matsumoto1, James K Chambers1, Kazumi Nibe2, Ryohei Kinoshita3, Ryohei Nishimura3, Hiroyuki Nakayama1, Kazuyuki Uchida1.   

Abstract

The biological behavior and immunohistochemical features of feline renal cell carcinoma (RCC) have not been well characterized. In the present study, immunohistochemical examinations were performed in 12 feline cases of RCC. The RCC consisted of solid ( n = 2), solid-tubular ( n = 2), tubular ( n = 3), papillary ( n = 2), tubulopapillary ( n = 2), and sarcomatoid ( n = 1) type lesions. Of the cases with RCC, 1 developed metastatic disease and 6 cases had no evidence of recurrence at 80 to 2292 days after surgery. One papillary-type tumor had cuboidal cells with scant cytoplasm and monomorphic nuclei, and the other had pseudostratified columnar cells with abundant cytoplasm. Immunohistochemistry revealed that the tumor cells in most cases were positive for cytokeratin (CK)7, CK20, KIT, and CD10, with the exception of cases of the solid type with clear cytoplasm (solid anaplastic), papillary type with columnar cells, and sarcomatoid types. A small number of tumor cells in the solid anaplastic and in the sarcomatoid types were positive for aquaporin-1. Increased expression of N-cadherin and Twist along with nuclear accumulation of β-catenin were observed in the sarcomatoid type. These results indicated that CK, KIT, and CD10 are relatively strongly expressed in most feline RCC. The solid anaplastic RCC exhibited CD10 expression with the absence of distal tubule marker expression. Although immunohistochemistry profiles were relatively consistent with those described in human RCC, the histopathologic features were different from those seen in humans. Epithelial-mesenchymal transition (EMT) marker expression in the current cases may suggest the involvement of an EMT-like mechanism in the development of sarcomatoid RCC in cats.

Entities:  

Keywords:  cats; epithelial mesenchymal transition (EMT); kidney; renal cell carcinoma; survival

Mesh:

Substances:

Year:  2018        PMID: 29759053     DOI: 10.1177/0300985818776055

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  1 in total

1.  Feline sarcomatoid renal cell carcinoma with peritoneal carcinomatosis and effusion.

Authors:  BinXi Wu; Brandy Kastl; Ada G Cino-Ozuna; Nora L Springer; Ravindra Thakkar; David Biller; William Whitehouse; Loren Easterwood; Thu Annelise Nguyen
Journal:  J Vet Diagn Invest       Date:  2021-10-29       Impact factor: 1.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.